Cargando…
IL-1β Inhibition in Cardiovascular Complications Associated to Diabetes Mellitus
Diabetes mellitus (DM) is a chronic disease that affects nowadays millions of people worldwide. In adults, type 2 diabetes mellitus (T2DM) accounts for the majority of all diagnosed cases of diabetes. The course of the T2DM is characterized by insulin resistance and a progressive loss of β-cell mass...
Autores principales: | Peiró, Concepción, Lorenzo, Óscar, Carraro, Raffaele, Sánchez-Ferrer, Carlos F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468794/ https://www.ncbi.nlm.nih.gov/pubmed/28659798 http://dx.doi.org/10.3389/fphar.2017.00363 |
Ejemplares similares
-
Visfatin/PBEF/Nampt: A New Cardiovascular Target?
por: Peiró, Concepción, et al.
Publicado: (2010) -
DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
por: Valencia, Inés, et al.
Publicado: (2020) -
The Angiotensin-(1-7)/Mas Axis Counteracts Angiotensin II-Dependent and -Independent Pro-inflammatory Signaling in Human Vascular Smooth Muscle Cells
por: Villalobos, Laura A., et al.
Publicado: (2016) -
Visfatin/Nampt: An Adipokine with Cardiovascular Impact
por: Romacho, Tania, et al.
Publicado: (2013) -
Visfatin as a Novel Mediator Released by Inflamed Human Endothelial Cells
por: Romacho, Tania, et al.
Publicado: (2013)